glp-1 news today pharma glp 1 meaning in What do new developments in and weight loss drugs World Pharma Today | Oral

doi:10.3389/fendo.2023.1215356 Parker CH, Slattery C, Brennan DJ, le Roux CW

Safety considerations for retatrutide research Responsible research requires thorough safety understanding regardless of vendor selection

Most of these patients had type 2 diabetes (90.5%) and obesity (75.2%)

[DOI] [PubMed] [Google Scholar] 9.Haynes A., Kersbergen I., Sutin A., Daly M., Robinson E

GLP-1 RAs are preferred second-line agents in patients with T2DM with established atherosclerotic cardiovascular diseases (ASCVD) in light of their demonstrated ASCVD benefit, high efficacy, low potential for hypoglycaemia and potential for weight loss

Reduced food intake means reduced micronutrient intake